Adicet Rings the Nasdaq Stock Market Closing Bell
Adicet (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor T cell therapies for cancer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Chen Schor, President and CEO, rings the Closing Bell.